Corpus Intelligence IC Memo — BECKLEY ARH 2026-04-26 03:44 UTC
IC Memo — BECKLEY ARH
Investment Committee Memorandum | WV | 72 beds | Grade C | EBITDA uplift $8.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BECKLEY ARH

CCN 510062 | RALEIGH, WV | 72 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BECKLEY ARH is a 72-bed under-performing / distressed in RALEIGH, WV with $109.2M in net patient revenue and a -37.8% operating margin. The hospital serves a payer mix of 36.0% Medicare, 4.9% Medicaid, and 59.1% commercial.

Thesis: Turnaround. Our ML models identify $8.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -37.8% to -30.4% (+736bps).

Net Revenue HCRIS$109.2M
Current EBITDA COMPUTED$-41.2M
Operating Margin COMPUTED-37.8%
Occupancy HCRIS84.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS25.5%
Distress Probability ML39.7%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
19
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -37.8% places it below the state median. Among 19 size-comparable peers (36-144 beds), the median margin is 4.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 19 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BECKLEY ARH (Target)WV72$109.2M-37.8%
PRINCETON COMMUNITY HOSPITALWV115$290.2M12.8%
WEIRTON MEDICAL CENTERWV127$182.4M9.4%
REYNOLDS MEMORIAL HOSPITALWV94$123.6M3.8%
LOGAN REGIONAL MEDICAL CENTERWV132$104.0M3.4%
DAVIS MEMORIAL HOSPITALWV90$100.9M-20.4%
ST FRANCIS HOSPITALWV40$58.5M30.5%
GREENBRIER VALLEY MEDICAL CENTWV58$50.8M4.3%
ENCOMPASS HEALTH REHABILITATIOWV96$47.0M15.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$70K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.3M
Clean Claim Rate
$70K
Total EBITDA Uplift$8.0M
Current EBITDA$-41.2M
+ RCM Uplift+$8.0M
Pro Forma EBITDA$-33.2M
Current Margin-37.8%
Pro Forma Margin-30.4%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-63.5M$-191.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-63.5M$-231.5M0.00x-100.0%
Bull Case9.0x11.0x$-57.1M$-225.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-57.1M$-262.9M0.00x-100.0%
Bear Case11.0x10.0x$-69.8M$-211.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-69.8M$-255.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 19 hospitals with 36-144 beds
  • Same-state prioritization (n=20)
  • Comp margins: P25=-7.0% / P50=4.1% / P75=14.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.